Bestatin (Ubenimex) Protocol — Complete Dosing & Administration Guide

Dosing

How muchdo I take?

Oral: Taken by mouth as a capsule, tablet, or liquid.

Bioavailability Varies by compound — many peptides are largely broken down in the gut, so little reaches the blood intact; some small molecules absorb well.

Standard Dose

30 mg

Frequency

Once daily

Duration

Long-term, alongside maintenance chemotherapy

30 mg by mouth once daily is the approved Japanese dose used as add-on therapy after leukemia remission. It helped patients, especially older adults, stay in remission longer [4][1].

Timing

Best time to take

Take Bestatin (Ubenimex) at the same time each day for consistent blood levels. Morning dosing with breakfast is often preferred, but follow your healthcare provider's specific instructions.

With food?

Bestatin (Ubenimex) can typically be taken with or without food. Taking it with a light meal may help reduce any GI discomfort. Avoid taking with grapefruit juice or high-fat meals unless specifically directed.

If stacking

Bestatin (Ubenimex) should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

Adjusting Your Dose

Increase if

+You are being treated for pulmonary arterial hypertension under physician guidance and require higher LTA4H inhibition

+Your oncologist recommends dose escalation based on insufficient immune response markers

+You have tolerated the starting dose well and are transitioning to the standard therapeutic dose

Decrease if

-You experience persistent gastrointestinal side effects at the current dose

-Liver function tests show elevated transaminases above acceptable thresholds

-You develop significant skin reactions or allergic symptoms

Signs of right dose

✓Stable or improving T-lymphocyte counts on blood work

✓Maintenance of complete remission in AML patients

✓Reduced frequency of infections during cancer treatment

✓Normal liver function tests during treatment

Dosing Calculator

Calculate Your Exact Dose

Step 1: Peptide Weight

Find the weight printed on your peptide vial label

Look here!

The peptide weight is printed on the label

The weight is on the label

Select Weight

Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)

Administration

How do Iuse it?

Reconstitution

What you need

•Bestatin (Ubenimex) in its prescribed form

•Clean, dry storage container

•Measuring device if applicable (oral syringe, measuring cup)

•Calendar or reminder app for dosing schedule

Example

Bestatin (Ubenimex) comes in pre-measured doses or forms. Follow the exact dosing instructions on your prescription label. No reconstitution or mixing is typically required for this formulation.

Use Bestatin (Ubenimex) exactly as prescribed. Each unit contains the labeled amount. Your healthcare provider will determine the appropriate dose based on your individual needs and response.

Injection

Route

Bestatin (Ubenimex) is administered Oral (capsule)—no injection required

Best sites

•Not applicable—this is not an injectable formulation

Technique

1.Follow the specific administration instructions for your Bestatin (Ubenimex) formulation

2.Take or apply as directed by your healthcare provider

3.Store properly between uses according to package instructions

Storage

Before reconstitution

Store Bestatin (Ubenimex) in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After reconstitution

Once reconstituted, Bestatin (Ubenimex) should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Signs of degradation

Solution appears cloudy, discolored, or contains visible particles (should be clear)

Product has been exposed to temperatures outside the recommended storage range

Product has been frozen (unless specifically designed for freeze-thaw stability)

Expiration date has passed or reconstituted solution has exceeded its use-by date

Unusual odor, color change, or visible contamination

Sample Daily Schedule

Morning

30 mg (1 capsule) injection

Site: Oral — swallow whole with water

Take at the same time each day for consistent plasma levels. Can be taken with or without food. For AML maintenance, this is the standard once-daily regimen.

Safety

Is itsafe?

Safety Profile

Bestatin (ubenimex) has an established safety profile based on decades of clinical use in Japan for AML maintenance therapy at 30 mg daily. The compound is generally well-tolerated, with the most common side effects being mild gastrointestinal symptoms and skin reactions. Japanese post-marketing surveillance and long-term clinical studies have not identified major safety concerns at standard doses. Phase 2 trials in the US for PAH and lymphedema also demonstrated acceptable safety profiles at higher doses.

Safety data is supported by Japanese regulatory approval, Phase 1-2 clinical trials, and decades of post-marketing surveillance. FDA orphan drug designation for PAH indicates adequate safety data for continued clinical development. Most safety data comes from Japanese clinical experience; data in non-Japanese populations is more limited.

Common Side Effects

Experienced by some users

Gastrointestinal discomfort

Mild nausea, diarrhea, or abdominal discomfort are the most frequently reported side effects with oral bestatin. These are typically transient and occur during the first week of treatment.

Management: Take with a small amount of food or water if stomach upset occurs. Symptoms usually resolve within a few days of continued use. If persistent, consider temporary dose reduction.

Skin rash or pruritus

Mild skin reactions including rash, itching, or urticaria have been reported in a subset of patients. These are generally mild and do not require discontinuation.

Management: Antihistamines may provide symptomatic relief. If rash is widespread or accompanied by systemic symptoms, discontinue and consult healthcare provider. Usually resolves within days of stopping treatment.

Facial flushing

Transient facial flushing or warmth may occur, particularly during the initial days of treatment, likely related to immune activation and histamine release.

Management: Usually self-limiting and resolves within 30-60 minutes of dosing. No treatment required. If persistent or bothersome, dose reduction may help.

Fatigue

Mild fatigue or malaise may occur as the immune system is stimulated. This is more commonly noted in patients concurrently receiving chemotherapy.

Management: Ensure adequate rest and hydration. Fatigue typically improves after the first 1-2 weeks of treatment. May be managed with dose timing adjustment to evening if daytime fatigue is problematic.

Less Common

•Elevated liver enzymes

•Mild leukopenia

These typically resolve with continued use or dose adjustment.

Stop and Seek Help If

×Severe allergic reaction (rash, swelling, difficulty breathing)

×Significant liver enzyme elevation (AST/ALT >3x upper limit of normal)

×Persistent or worsening side effects despite dose adjustment

×Disease relapse requiring change in treatment protocol

×Physician determines treatment goals have been achieved or treatment is no longer beneficial

Always consult with your healthcare provider before stopping bestatin, especially during cancer treatment. Abrupt discontinuation during AML maintenance therapy should only be done under medical supervision.

Interactions

With other peptides

✓Both enhance immune function through complementary mechanisms — Thymosin Alpha-1 promotes thymic T-cell maturation while bestatin enhances peripheral T-cell activation. Combination may provide synergistic immune support but should be monitored for excessive immune stimulation.

✓Complementary immune enhancement pathways. TP-5 modulates thymic function while bestatin acts on aminopeptidases. No known negative interactions, but combination has not been extensively studied.

✓BPC-157 focuses on tissue repair while bestatin targets immune function. No overlapping mechanisms or known interactions. Can likely be used concurrently without issues.

With medications

✓Chemotherapy agents (cytarabine, daunorubicin) - Bestatin is specifically designed and approved to be used alongside AML chemotherapy. Clinical trials demonstrated synergistic benefits with standard induction and maintenance regimens.

!Immunosuppressants (cyclosporine, tacrolimus) - Bestatin's immunostimulatory effects directly counteract immunosuppressive therapy. Avoid concurrent use or use only with careful immune monitoring.

!ACE inhibitors - Bestatin inhibits aminopeptidases involved in angiotensin metabolism, which may potentiate the hypotensive effects of ACE inhibitors. Monitor blood pressure closely if used together.

✓Antibiotics - No known negative interactions with common antibiotics. Bestatin may complement antibiotic therapy by enhancing immune clearance of infections.

With supplements

✓Vitamin D - Vitamin D supports immune function through complementary pathways and may enhance bestatin's immunostimulatory effects. Safe to combine.

✓Zinc - Zinc is essential for proper immune cell function and T-lymphocyte development. May complement bestatin's immune-enhancing effects. Safe to combine.

✓Green tea extract (EGCG) - EGCG has aminopeptidase inhibitory properties that may overlap with bestatin. While generally safe, combining multiple aminopeptidase inhibitors may lead to additive effects. Use with awareness.

Want the Full Picture?

View the complete Bestatin (Ubenimex) research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ.